Wolverine Trading, LLC Dexcom Inc Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 8,606 shares of DXCM stock, worth $690,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,606

Previous 16,263 47.08%

Holding current value

$690,545

Previous $1.84 Million 68.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $490,048 - $888,671	-7,657 Reduced 47.08%	8,606 $576,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $1.79 Million - $2.28 Million	16,263 New	16,263 $1.84 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $159,585 - $262,474	2,114 New	2,114 $262,000
Q2 2023 Aug 23, 2023	BUY	$112.47 - $130.98 $877,041 - $1.02 Million	7,798 New	7,798 $1 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $2.88 Million - $4.16 Million	33,920 Added 50.05%	101,686 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $1.75 Million - $2.16 Million	22,960 Added 51.24%	67,766 $5.56 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.94 Million - $3.79 Million	28,537 Added 175.41%	44,806 $3.38 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $978,808 - $1.35 Million	-10,404 Reduced 39.01%	16,269 $8.44 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3.81 Million - $4.78 Million	-29,370 Reduced 52.41%	26,673 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $2.61 Million - $3.5 Million	24,423 Added 77.24%	56,043 $30.6 Million
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $923,124 - $1.23 Million	11,398 Added 56.36%	31,620 $13.5 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $769,299 - $950,306	9,073 Added 81.38%	20,222 $7.02 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $701,142 - $939,350	8,989 Added 416.16%	11,149 $4.05 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $730,078 - $863,389	-7,644 Reduced 77.97%	2,160 $869,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $15,168 - $25,492	-242 Reduced 2.41%	9,804 $3.9 Million
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $288,938 - $457,258	6,046 Added 151.15%	10,046 $2.79 Million
Q4 2019 Feb 12, 2020	SELL	$36.62 - $57.29 $124,581 - $194,900	-3,402 Reduced 45.96%	4,000 $865,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $29,311 - $40,583	1,086 Added 17.19%	7,402 $876,000
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $20,256 - $28,755	1,551 Added 32.55%	6,316 $468,000
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $68,098 - $94,187	-6,124 Reduced 56.24%	4,765 $273,000
Q3 2017 Nov 15, 2017	BUY	$11.36 - $18.98 $123,699 - $206,673	10,889	10,889 $533,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Dexcom Inc Transaction History